2019
DOI: 10.1002/dc.24287
|View full text |Cite
|
Sign up to set email alerts
|

Cytological features of breast implant‐associated anaplastic large cell lymphoma in pleural effusion

Abstract: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a very rare CD30-positive ALK-negative T-cell non-Hodgkin lymphoma included as a provisional entity in the 2017 WHO classification of lymphoid neoplasms. BIA-ALCL arises as proliferating cells over the surface of the implant. It is generally an indolent disease if confined within the fibrous capsule. In contrast, mass and/or infiltration beyond the capsule is much more aggressive. This report describes a case of infiltrative BIA-ALCL with m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 24 publications
(47 reference statements)
0
4
0
Order By: Relevance
“…BIA-ALCL is supposed to be associated with chronic inflammation (11), which is further supported by scientific observations that chronic inflammation, induced by cytokines or ligands, triggers events that cause genetic instability leading to lymphoma transformation (12). In cases where this disease leads to the formation of only a periprosthetic fluid effusion, it usually follows an indolent clinical course and has an excellent prognosis compared to lymphoproliferative disease with mass formation or to systemic ALK-negative ALCL, which may have more aggressive pathways (13). Patients with BIA-ALCL, undergone total capsulectomy and breast implant remove, have been shown to present a better overall and disease-free survival with respect to patients treated with partial capsulectomy, systemic therapy, or radiotherapy (8).…”
Section: Discussionmentioning
confidence: 94%
“…BIA-ALCL is supposed to be associated with chronic inflammation (11), which is further supported by scientific observations that chronic inflammation, induced by cytokines or ligands, triggers events that cause genetic instability leading to lymphoma transformation (12). In cases where this disease leads to the formation of only a periprosthetic fluid effusion, it usually follows an indolent clinical course and has an excellent prognosis compared to lymphoproliferative disease with mass formation or to systemic ALK-negative ALCL, which may have more aggressive pathways (13). Patients with BIA-ALCL, undergone total capsulectomy and breast implant remove, have been shown to present a better overall and disease-free survival with respect to patients treated with partial capsulectomy, systemic therapy, or radiotherapy (8).…”
Section: Discussionmentioning
confidence: 94%
“…Pleural effusion post-breast augmentation surgery was first described by Stevens et al in 1987 [ 5 ]. Pleural effusion is one of the rarest complications for this type of surgery [ 5 , 6 ], and when found, underlying conditions such as anaplastic large cell lymphoma [ 7 , 8 ], implant rupture [ 5 ], or reactivation of latent infections [ 9 ] might explain the development of this complication. Shaik et al described a case without any underlying condition, and after a pathologic evaluation that included an examination of the pleural fluid, they associated the pleural effusion with an FBR due to the presence of silicone particles and mononuclear cells [ 6 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, cases presenting with lymph node involvement (stage IIB-IV) are associated with reduced overall survival and can be fatal in some circumstances. 61 Fatalities have also occurred without lymph node involvement, when the lymphoma cells infiltrated through the chest wall, pleural space and mediastinum 62 .…”
Section: Breast Implant-associated Lymphomamentioning
confidence: 99%